ArticleScientific reports2025
Deep learning model for grading carcinoma with Gini-based feature selection and linear production-inspired feature fusion.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain tumor classification using fractional Laplacian image enhancement and vision transformer.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most common types of kidneys and liver cancer are renal cell carcinoma (RCC) and hepatic cell carcinoma (HCC), respectively. Accurate grading of these carcinomas is essential for determining the most appropriate treatment strategies, including surgery or pharmacological interventions. Traditional deep learning methods often struggle with the intricate and complex patterns seen in histopathology images of RCC and HCC, leading to inaccuracies in classification. To enhance the grading accuracy for liver and renal cell carcinoma, this research introduces a novel feature selection and fusion framework inspired by economic theories, incorporating attention mechanisms into three Convolutional Neural Network (CNN) architectures-MobileNetV2, DenseNet121, and InceptionV3-as foundational models. The attention mechanisms dynamically identify crucial image regions, leveraging each CNN's unique strengths. Additionally, a Gini-based feature selection method is implemented to prioritize the most discriminative features, and the extracted features from each network are optimally combined using a fusion technique modeled after a linear production function, maximizing each model's contribution to the final prediction. Experimental evaluations demonstrate that this proposed approach outperforms existing state-of-the-art models, achieving high accuracies of 93.04% for RCC and 98.24% for LCC. This underscores the method's robustness and effectiveness in accurately grading these types of cancers. The code of our method is publicly available in https://github.com/GHOSTCALL983/GRADE-CLASSIFICATION .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.